Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
06/20/2007 | EP1379254B1 Use of bile acid or bile salt fatty acid conjugates |
06/20/2007 | EP1154796B1 Novel albumin-free factor viii formulations |
06/20/2007 | EP0789593B1 Yeast-based delivery vehicles |
06/20/2007 | CN1984903A 1 (indole-6-carbonyl-D-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine D-tartrate |
06/20/2007 | CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
06/20/2007 | CN1984682A Solid medicinal preparation |
06/20/2007 | CN1984655A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
06/20/2007 | CN1981873A Method of manufacturing micro colloidal particle and use of the same |
06/20/2007 | CN1981853A Chinese-medicinal decoction for treating heart disease and cerebral thrombosis and its making method |
06/20/2007 | CN1981848A Extraction and use for cold-pressed concentrate composition of celery, Chinese onion and onion |
06/20/2007 | CN1981840A Chinese-medicinal composition with anti-inflammatory and hemostasis functions and its production |
06/20/2007 | CN1981802A Chinese-medicinal preparation for treating cardiovascular diseases, its production and use |
06/20/2007 | CN1981777A Chinese medicinal preparation for treating cardio vascular diseases, its making method and use |
06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
06/20/2007 | CN1322126C Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
06/20/2007 | CN1322013C Soluble high branched glucose polymer and its producing process |
06/20/2007 | CN1322001C Novel compounds that inhibit factor Xa activity |
06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
06/20/2007 | CN1321961C New method for picking-up purified resveratrol from giant knotweed |
06/20/2007 | CN1321666C Combination of medication of containing astragalus root and dragon's blood resin and application |
06/20/2007 | CN1321650C Effervescent tables for treating thrombus, and its prepn. method |
06/20/2007 | CN1321630C Method for preparing blood flow cutting off dispersing tablet |
06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
06/19/2007 | US7232797 Erythropoietin dosing regimen for treating anemia |
06/19/2007 | CA2482021C Removal of adenine during a process of pathogen reducing blood and blood components |
06/19/2007 | CA2437468C Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
06/19/2007 | CA2195127C Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
06/19/2007 | CA2159005C Method and apparatus for encapsulation of biologically-active substances in cells |
06/19/2007 | CA2127107C Methods and compositions for reducing blood loss |
06/14/2007 | WO2007044560A3 Modulators of atp-binding cassette transporters |
06/14/2007 | US20070135636 Use of cyclic bioisosters of purine system derivatives for treating diseases produced by disorders of niterergic and dopaminergic systems |
06/14/2007 | US20070135409 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
06/14/2007 | US20070135354 Hematopoietic stimulation |
06/14/2007 | DE102005058369A1 Ungesättigte Fettsäuren als Thrombin-Inhibitoren Unsaturated fatty acids as inhibitors of thrombin |
06/14/2007 | CA2633102A1 Method for preparing a factor h concentrate and the use thereof in the form of a drug |
06/13/2007 | EP1794126A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
06/13/2007 | EP1794125A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
06/13/2007 | EP1793831A2 Method of treatment for or protection against lymphedema |
06/13/2007 | EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
06/13/2007 | EP1330425B1 C-nitroso compounds and use thereof |
06/13/2007 | EP1299358B1 Pyridoxine and pyridoxal analogues as cardiovascular therapeutics |
06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
06/13/2007 | EP0788546B9 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
06/13/2007 | CN1980673A A method for the prevention of thromboembolic disorders |
06/13/2007 | CN1978656A Induced differentiation of hemopoietic stem/progenitor cell into erythroid progenitor cells |
06/13/2007 | CN1978452A New process for preparing isoquercitrin |
06/13/2007 | CN1977969A Drug injection of recombinant human erythropoietin |
06/13/2007 | CN1977925A Cardio-cerebro micro pill for treating qi-yin insufficiency and erythrocytosis, and its preparing method |
06/13/2007 | CN1977902A Injection total saponins of paeonia powder without additive material |
06/13/2007 | CN1977892A Method for regulating baicalin and baicalein ratio in scutellariae root extract |
06/13/2007 | CN1977838A Pharmaceutical use of senkyunolide A, and medicinal composition containing it and its prepairng method |
06/13/2007 | CN1321134C Hetergeneous product of bio-active protein and its preparing process |
06/13/2007 | CN1321129C Inhibitors of caspases |
06/13/2007 | CN1320917C Dripping pills of 'Xiao Chaihu' |
06/13/2007 | CN1320899C Medicine for treating ulcer haemorrhage |
06/13/2007 | CN1320880C Improved formulation for topical non-invasive application in vivo |
06/12/2007 | US7230009 Pyridoxal analogues and methods of treatment |
06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
06/12/2007 | CA2354023C Phenylglycine derivatives |
06/07/2007 | WO2007063200A1 Slow-release composition, method for the preparation thereof, and use of the same |
06/07/2007 | WO2007062546A1 Iron-saccharide complexs easy to reconstitute and the method for manufacture them |
06/07/2007 | WO2007024472A3 USE OF PAR- l/PAR- 4 INHIBITORS FOR TREATING OR PREVENTING VASCULAR DISEASES |
06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
06/07/2007 | US20070129371 Novel ethylenediamine derivatives |
06/07/2007 | US20070129348 Receptor antagonist |
06/07/2007 | US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia |
06/07/2007 | US20070129285 Protein a compositions and methods of use |
06/07/2007 | US20070128616 Aggrecanase molecules |
06/07/2007 | US20070128603 Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
06/07/2007 | US20070128198 Compositions comprising antibodies to human fgl2 |
06/07/2007 | US20070128181 Administering within 12 hours after cardiac surgery to patient a blood clotting inhibitor such as a combination of dipyridamole and aspirin, wherein cardiac surgery does not include vein graft coronary artery bypass graft surgery; decreases complications without significant adverse effects; efficiency |
06/07/2007 | CA2632547A1 Slow-release composition, method for the preparation thereof, and use of the same |
06/06/2007 | EP1793006A2 Nucleic acid ligands and improved methods for producing the same |
06/06/2007 | EP1792997A1 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
06/06/2007 | EP1792917A1 Surface-modified serum albumin-metal porphyrin composite, and oxygen infusion containing the same |
06/06/2007 | EP1792537A1 Method of constructing clone mammal |
06/06/2007 | EP1791832A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
06/06/2007 | EP1791813A1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
06/06/2007 | EP1791597A2 Carbonyl compound-containing drug and the use thereof |
06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
06/06/2007 | EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
06/06/2007 | DE102005052174A1 Phenylen-bis-oxazolidin-Derivate und ihre Verwendung Phenylene-bis-oxazolidine derivatives and their use |
06/06/2007 | CN1976903A Factor VóÄa inhibitor |
06/06/2007 | CN1976712A Medical solution, method for producing and use thereof |
06/06/2007 | CN1976695A Compositions for urinary dysfunction and edema containing decursin and/or decursinol angelate, or angelica extract containing decursin and /or decursinol angelate |
06/06/2007 | CN1976682A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active component |
06/06/2007 | CN1973894A Medicinal food for treating pregnancy edema and its prepn |
06/06/2007 | CN1973864A Medicine composition for treating hematuria and nephropyelitis and its prepn |
06/06/2007 | CN1973853A Hemostatic and analgetic medicine composition and its prepn process |
06/06/2007 | CN1319967C 2-acylaminothiazole derivative or salt thereof |
06/06/2007 | CN1319592C Pharmaceutical formulations |
06/06/2007 | CN1319551C Method for extracting volatile oil and liposoluble alkaloid from plumula nelumbini |
06/06/2007 | CN1319549C Method for extracting general iridoid glycoside from 'Duyiwei' of Tibet medicine and application |
06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
06/05/2007 | US7226943 Antilipemic agents |
06/05/2007 | US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents |
06/05/2007 | US7226785 A single-stranded oligonucleotide with a DNA domain having at least one mismatch with respect to genetic sequence to be altered |